LipitorCare News » June 07

Lipitor Lowers Risk Of Coronary Events, Stroke
25 June, 2007

Pfizer Inc. (PFE) said Monday its Lipitor drug reduces the risk of stroke, coronary heart disease events and major coronary events in type-2 diabetes patients who had experienced a recent stroke, according to a new analysis of a previous trial.

The analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial indicated that Lipitor reduced the risk of stroke by 30%, and coronary heart disease events and major coronary events, including cardiac death and heart attack, by 51%, compared with a placebo.

An additional analysis of 781 patients who had a recent stroke or mini-stroke, but no known coronary heart disease, showed that Lipitor reduced the risk of coronary heart disease events by 43% compared with those taking placebo.

The risk of stroke and major coronary events was lowered by 12% and 26%, respectively, Pfizer said.

Source: CNN